Evinacumab Lowers LDL Cholesterol in Refractory Hypercholesterolemia
In this phase 2 trial, patients with hypercholesterolemia and clinical atherosclerotic cardiovascular disease were recruited from 85 sites across 20 countries.
In this phase 2 trial, patients with hypercholesterolemia and clinical atherosclerotic cardiovascular disease were recruited from 85 sites across 20 countries.
Low-intensity warfarin therapy was found to be as effective as standard-intensity I warfarin in lowering the risk for thromboembolism in older patients with nonvalvular atrial fibrillation.
The use of paclitaxel-coated vs uncoated endovascular devices for the treatment of peripheral artery disease was not associated with increased mortality.
A novel vs reference DAPT regimen after staged PCI was found to reduce the risk for bleeding in patients with acute coronary syndrome.
A long-term very low carbohydrate dietary intervention was associated with a reduction in the concentration of small LDL particles in patients with type 2 diabetes.
Age at diagnosis, but not duration, of hypertension was found to be associated with cognitive decline.
Individuals living with HIV, particularly those with comorbid kidney disease, were found to be at increased risk for cardiovascular disease.
A new dissociated pulmonary vein activity was detected in a patient.
Patients with type 2 diabetes mellitus at risk for heart failure treated with metformin may have reduced deterioration of LV filling pressures and myocardial relaxation.
Results of this study contradict the currently held paradigm of stenosis-related CVD risk.